Infertility Treatment Affordability Act of 2025

Referred to the House Committee on Ways and Means.

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Ways and Means Committee
  House of Representatives

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• FERRING PHARMACEUTICALS, INC.
  for FERRING PHARMACEUTICALS, INC. · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• FERRING PHARMACEUTICALS, INC.
  for FERRING PHARMACEUTICALS, INC. · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• FERRING PHARMACEUTICALS, INC.
  for FERRING PHARMACEUTICALS, INC. · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)
• THE MCMANUS GROUP
  for EMD SERONO, INC. · Massachusetts · 4th Quarter 2025 (Oct 1 - Dec 31)
• FERRING PHARMACEUTICALS, INC.
  for FERRING PHARMACEUTICALS, INC. · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)
• THE MCMANUS GROUP
  for EMD SERONO, INC. · Massachusetts · 3rd Quarter 2025 (July 1 - Sep 30)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  7 filings
• SENATE
  7 filings
• Commerce, Dept of (DOC)
  2 filings
• U.S. Trade Representative (USTR)
  2 filings
• Health & Human Services, Dept of (HHS)
  1 filing
• White House Office
  1 filing

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.